Leqvio® (inclisiran)
| Drug Name | Leqvio® (inclisiran) |
| Manufacturer | Novartis Pharmaceuticals |
| Route of Administration | Subcutaneous |
| Approved Indication | The treatment of adults with heterozygous familial hypercholesterolemia (HeFH) or clinical atherosclerotic cardiovascular disease (ASCVD), who require additional lowering of low-density lipoprotein cholesterol (LDL-C) |
| Disease | Primary Hyperlipidemia; Heterozygous Familial Hypercholesterolemia (HeFH) |
| Therapeutic Area | Cardiology |
| Enrollment Form Link | Enrollment Form |
| Phone Numbers | 800-372-6153 (Enrollment), 877-515-9670 (Support) |
| Product Website | leqvio.com |